Key statistics
As of last trade, Charles River Laboratories International Inc (CRL:NYQ) traded at 196.55, 11.37% above the 52 week low of 176.48 set on Oct 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 194.38 |
---|---|
High | 197.09 |
Low | 193.26 |
Bid | 196.56 |
Offer | 196.91 |
Previous close | 194.19 |
Average volume | 847.92k |
---|---|
Shares outstanding | 51.14m |
Free float | 50.67m |
P/E (TTM) | 24.24 |
Market cap | 9.93bn USD |
EPS (TTM) | 8.01 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:15 GMT.
More ▼
- Charles River Laboratories to Present at UBS and Jefferies Conferences
- Charles River Laboratories Announces Third-Quarter 2024 Results
- Charles River Launches New Retrogenix® Non-Human Protein Library
- Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
- Charles River Provides Translational Expertise at Neuroscience 2024
- Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
- Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
- Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
More ▼